User contributions for Lazy

31 March 2024

• 10:0310:03, 31 March 2024 diff hist +18‎ N Property:Has Toxicity Explanation ‎ Created page with "Has type::Text" current
• 10:0010:00, 31 March 2024 diff hist +291‎ Category:Other Chemotherapy and Cancer Drugs ‎No edit summary
• 09:5909:59, 31 March 2024 diff hist 0‎ Category:Antibody-Drug Conjugates and other protein-drug conjugates ‎ →‎List of Treatments current
• 09:5709:57, 31 March 2024 diff hist +146‎ Category:Antibody-Drug Conjugates and other protein-drug conjugates ‎No edit summary
• 09:5509:55, 31 March 2024 diff hist +14‎ Category:Antibody-Drug Conjugates and other protein-drug conjugates ‎No edit summary
• 09:5409:54, 31 March 2024 diff hist +14‎ Category:Nutraceuticals ‎No edit summary
• 09:5409:54, 31 March 2024 diff hist +14‎ Category:Hormones ‎No edit summary current
• 09:5409:54, 31 March 2024 diff hist +14‎ Category:Repurposed Drugs ‎No edit summary
• 09:5109:51, 31 March 2024 diff hist +16‎ Template:TreatmentInfo ‎No edit summary
• 09:4809:48, 31 March 2024 diff hist +15‎ Main Page ‎No edit summary
• 06:2406:24, 31 March 2024 diff hist −31‎ Main Page ‎No edit summary
• 06:2306:23, 31 March 2024 diff hist +920‎ Main Page ‎No edit summary

30 March 2024

• 21:0121:01, 30 March 2024 diff hist −1‎ Main Page ‎No edit summary
• 20:4920:49, 30 March 2024 diff hist +1,903‎ N CPT-11 (Irinotecan) ‎ Created page with "{{TreatmentInfo |drug_name=CPT-11 (Irinotecan) |FDA_approval=Approved for the treatment of colon cancer; under investigation for recurrent glioma |used_for=Recurrent Glioblastoma Multiforme (GBM) and other malignant gliomas |clinical_trial_phase=Phase I/II trials in combination with other therapies |common_side_effects=Hematologic, gastrointestinal, and hepatic toxicities noted; acceptable safety profile in combination regimens |OS_without=Not directly specified; histori..."
• 20:4720:47, 30 March 2024 diff hist +1,948‎ N Carboplatin ‎ Created page with "{{TreatmentInfo |drug_name=Carboplatin |FDA_approval=Yes, approved for various cancers including ovarian and lung cancer; used off-label for GBM |used_for=Recurrent Glioblastoma Multiforme (GBM) and high-grade glioma |clinical_trial_phase=Exploratory and Phase 1/2 trials for recurrent glioma in combination with other agents |common_side_effects=Less toxicity compared to cisplatin, but may include myelosuppression, nausea, and potential for liver enzyme elevation |OS_with..."
• 20:4520:45, 30 March 2024 diff hist +2,165‎ N Fotemustine ‎ Created page with "{{TreatmentInfo |drug_name=Fotemustine |FDA_approval=Available in Europe, not FDA-approved in the United States for GBM |used_for=Recurrent Glioblastoma Multiforme (GBM) after the standard Stupp protocol treatment |clinical_trial_phase=Varied, with multiple studies evaluating efficacy and optimal scheduling |common_side_effects=Not specified, typical of nitrosoureas may include myelosuppression, nausea, and liver enzyme elevation |OS_without=Not specified |OS_with=Not sp..."
• 20:4220:42, 30 March 2024 diff hist +2,138‎ N BCNU (Carmustine) ‎ Created page with "{{TreatmentInfo |drug_name=BCNU (Carmustine) |FDA_approval=Yes, approved for treatment of brain tumors, multiple myeloma, Hodgkin's disease, and non-Hodgkin's lymphomas |used_for=Recurrent Glioblastoma Multiforme (GBM) after radiation treatment |clinical_trial_phase=Various, given its long history of use |common_side_effects=Hepatic and pulmonary toxicity, myelosuppression |OS_without=Not specified in the provided context |OS_with=Not specified in the provided context |P..."
• 20:3920:39, 30 March 2024 diff hist +1,923‎ N VAL-083 (Dianhydrogalactitol) ‎ Created page with "{{TreatmentInfo |drug_name=VAL-083 (Dianhydrogalactitol) |FDA_approval=Approved in China for CML and lung cancer; not yet approved outside of China for GBM |used_for=Recurrent Glioblastoma Multiforme (GBM) with unmethylated MGMT promoter |clinical_trial_phase=Phase 2 (ongoing evaluation in GBM AGILE for various GBM subtypes) |common_side_effects=Myelosuppression, including neutropenia and lymphopenia; some instances of serious adverse events possibly related to VAL-083 |..."
• 10:0810:08, 30 March 2024 diff hist 0‎ BCNU (Carmustine) and Gliadel (Carmustine Wafers) ‎No edit summary
• 09:2009:20, 30 March 2024 diff hist +24‎ N Template:CustomTextDisplay ‎ Created page with "{{{Has original text|}}}" current
• 09:2009:20, 30 March 2024 diff hist +36‎ Main Page ‎ →‎Optune (formerly NovoTTF-100A) by Novocure
• 09:1609:16, 30 March 2024 diff hist +23‎ Main Page ‎ →‎Optune (formerly NovoTTF-100A) by Novocure
• 09:1509:15, 30 March 2024 diff hist +5‎ Main Page ‎ →‎Available Treatments
• 09:1309:13, 30 March 2024 diff hist +23‎ Template:TreatmentInfo ‎No edit summary
• 09:1109:11, 30 March 2024 diff hist +80‎ Main Page ‎ →‎Optune (formerly NovoTTF-100A) by Novocure
• 09:0909:09, 30 March 2024 diff hist +1‎ Template:TreatmentInfo ‎No edit summary
• 09:0809:08, 30 March 2024 diff hist +105‎ Template:TreatmentInfo ‎No edit summary
• 09:0709:07, 30 March 2024 diff hist +154‎ Next-Generation CAR T-Cell Therapy for GBM ‎No edit summary current
• 09:0409:04, 30 March 2024 diff hist +2,325‎ N Next-Generation CAR T-Cell Therapy for GBM ‎ Created page with "{{TreatmentInfo |drug_name=Next-Generation CAR T-Cell Therapy for GBM |FDA_approval=In trial phase for GBM; FDA-approved for other cancers |used_for=Recurrent Glioblastoma Multiforme (GBM) |clinical_trial_phase=Phase 1 (INCIPIENT trial among others) |common_side_effects=Fevers, altered mental status shortly after infusion, significant but manageable neurotoxicity |OS_without=Median survival for recurrent GBM typically less than one year |OS_with=Not fully established; dr..." Tag: Visual edit: Switched
• 08:3508:35, 30 March 2024 diff hist +51‎ Main Page ‎ →‎Vaccines Tag: Visual edit
• 08:3408:34, 30 March 2024 diff hist +106‎ Main Page ‎ →‎Promising new Treatments Tag: Visual edit
• 08:3008:30, 30 March 2024 diff hist −1‎ Main Page ‎ →‎Other Chemotherapy and Cancer Drugs Tag: Visual edit

29 March 2024

• 23:4023:40, 29 March 2024 diff hist +1,820‎ EGFR inhibitors: Iressa, Tarceva, and Erbitux (gefitinib, erlotinib, and ‎No edit summary current
• 23:3523:35, 29 March 2024 diff hist 0‎ Main Page ‎ →‎Other Chemotherapy and Cancer Drugs
• 23:3423:34, 29 March 2024 diff hist +48‎ Main Page ‎ →‎Other Chemotherapy and Cancer Drugs
• 23:3323:33, 29 March 2024 diff hist +16,888‎ Main Page ‎ →‎Other Chemotherapy and Cancer Drugs
• 23:2923:29, 29 March 2024 diff hist −64‎ Radiation via Monoclonal Antibodies ‎No edit summary
• 23:2823:28, 29 March 2024 diff hist +446‎ Main Page ‎ →‎Radiation via Monoclonal Antibodies
• 21:5721:57, 29 March 2024 diff hist +636‎ Main Page ‎ →‎Proton radiation therapy
• 21:5621:56, 29 March 2024 diff hist +503‎ Main Page ‎No edit summary
• 21:5221:52, 29 March 2024 diff hist +79‎ Gamma Knife Radiosurgery ‎No edit summary
• 21:5121:51, 29 March 2024 diff hist +1,721‎ N Gamma Knife Radiosurgery ‎ Created page with "{{TreatmentInfo |drug_name=Gamma Knife Radiosurgery (GKRS) for GBM |FDA_approval=Yes |used_for=Newly diagnosed Glioblastoma Multiforme (GBM) |clinical_trial_phase=N/A (Established treatment modality) |common_side_effects=Lower compared to traditional GBM treatments, with no significant radiation-induced toxicities reported in recent studies. |OS_without=14-16 months with standard treatment. |OS_with=Comparable to standard treatment, specifics depend on individual patient..."
• 21:3721:37, 29 March 2024 diff hist −464‎ Radiation via Monoclonal Antibodies ‎No edit summary
• 21:3521:35, 29 March 2024 diff hist +2,677‎ N Radiation via Monoclonal Antibodies ‎ Created page with "<includeonly> {| class="wikitable" |- ! Property !! Information |- | Drug Name || Radiation via Monoclonal Antibodies |- | FDA Approval || Under research, not yet FDA-approved for general use |- | Used for || Glioblastoma (GBM) and potentially other high-grade glioma tumors |- | Clinical Trial Phase || Various phases, with some treatments in early clinical trials |- | Common Side Effects || Side effects vary depending on the specific monoclonal antibody and radioactive c..."
• 17:4117:41, 29 March 2024 diff hist 0‎ Main Page ‎ →‎Proton radiation therapy
• 17:4017:40, 29 March 2024 diff hist −130‎ Main Page ‎ →‎Proton radiation therapy
• 17:2817:28, 29 March 2024 diff hist 0‎ Main Page ‎ →‎Proton radiation therapy
• 17:2417:24, 29 March 2024 diff hist 0‎ Main Page ‎ →‎Proton radiation therapy
• 17:2317:23, 29 March 2024 diff hist 0‎ Main Page ‎ →‎Proton radiation therapy
• 17:2217:22, 29 March 2024 diff hist 0‎ Main Page ‎ →‎Proton radiation therapy